# Neuro-Oncology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/neuro-oncology/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 1522-8517 |
| ISSNs | 1522-8517,1523-5866 |
| OpenAlex ID | https://openalex.org/S106908163 |
| Publisher | Oxford University Press |

## Journal papers

Showing 12 of 44.

- [TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL](https://scholariq.org/papers/tert-promoter-mutations-occur-frequently-in-gliomas-and-a-subset-of-tumors/)
- [Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma](https://scholariq.org/papers/establishing-percent-resection-and-residual-volume-thresholds-affecting-survival/)
- [Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma](https://scholariq.org/papers/phase-iii-randomized-trial-of-ced-of-il13-pe38qqr-vs-gliadel-wafers-for/)
- [Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study](https://scholariq.org/papers/targeted-therapy-for-high-grade-glioma-with-the-tgf-2-inhibitor-trabedersen/)
- [Stereotactic modulation of blood-brain barrier permeability to enhance drug delivery](https://scholariq.org/papers/stereotactic-modulation-of-blood-brain-barrier-permeability-to-enhance-drug/)
- [Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques](https://scholariq.org/papers/imaging-patterns-predict-patient-survival-and-molecular-subtype-in-glioblastoma/)
- [Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology](https://scholariq.org/papers/long-term-follow-up-of-the-multicenter-multidisciplinary-treatment-study-hit-lgg/)
- [Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1](https://scholariq.org/papers/assessment-of-benign-tumor-burden-by-whole-body-mri-in-patients-with/)
- [Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging](https://scholariq.org/papers/regional-variation-in-histopathologic-features-of-tumor-specimens-from-treatment/)
- [Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma](https://scholariq.org/papers/prognostic-factors-for-survival-in-676-consecutive-patients-with-newly-diagnosed/)
- [Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network](https://scholariq.org/papers/primary-cns-lymphoma-at-first-relapse-progression-characteristics-management-and/)
- [Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging](https://scholariq.org/papers/evaluation-of-brain-tumor-vessels-specific-contrast-agents-for-glioblastoma/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.